Glympse Bio

• Wendy Winckler

• Eric Kai Huang

Sources: reporter.nih.gov

• National Cancer Institute

  R44, Early detection of HCC using noninvasive activity-based nanosensors, R44CA228743, $964K, 2019–2023, Aug 19, 2021

Sources: reporter.nih.gov

• Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial

  Consulting or advice, Feb 5, 2026

• Relationship Between Metabolic and Histological Responses in People With Metabolic Dysfunction- Associated Steatohepatitis With and Without Type 2 Diabetes: Participant-Level Exploratory Analysis of the SYNERGY-NASH Trial With Tirzepatide

  Consulting or advice, Fees or honoraria, Dec 1, 2025

• Innate immune activation: Parallels in alcohol use disorder and Alzheimer's disease

  Shares or equity, Sep 9, 2022

Sources: pubmed.ncbi.nlm.nih.gov